產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-EPOR抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-EPOR抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-EPOR
Cat. Number:
Anti-EPOR抗體KL-1424R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The erythropoietin receptor (EPOR) is a member of the cytokine receptor family. There are several isoforms including: Anti-EPOR抗體EPOR-F (full length), EPOR-S (soluble form), and EPOR-T (truncated form). Upon erythropoietin (EPO) binding, the EPOR activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated EPOR appears to have a role in erythroid cell survival. Defects in the EPOR may produce erythroleukemia and familial erythrocytosis. A functional EPOR is found in the cardiovascular system, including endothelial cells and cardiomyocytes, and data suggest that the EPO/EPO receptor system plays an important role in cardiac function. In animal studies, treatment with EPO during ischemia/reperfusion in the heart has been shown to limit the infarct size and the extent of apoptosis.
Also known as:
erythropoietin receptor; Anti-EPOR抗體EPO R; EPO Receptor; Erythropoietin receptor precursor; EPOR_HUMAN; MGC138358.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human EPOR.
●
Predicted Molecular Weight: 56kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-EPOR抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:50-500 IF=1:100-500
Not yet tested in other applications. Anti-EPOR抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-EPOR抗體
Optimal working dilutions must be determined by the end user.
kl793Ra01 S100鈣結(jié)合蛋白A9(S100A9)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A9 (S100A9)
kl908Hu02 聚集蛋白聚糖(AGC)多克隆抗體 Polyclonal Antibody to Aggrecan (AGC)
kl956Ra01 谷胱甘肽S轉(zhuǎn)移酶α5(GSTα5)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Alpha 5 (GSTa5)
kl985Ra01 上皮型脂肪酸結(jié)合蛋白(FABP5)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 5, Epidermal (FABP5)
kl015Hu01 S100鈣結(jié)合蛋白A3(S100A3)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A3 (S100A3)
kl015Ra01 S100鈣結(jié)合蛋白A3(S100A3)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A3 (S100A3)
kl021Ra01 S100鈣結(jié)合蛋白A5(S100A5)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A5 (S100A5)
kl741Hu01 胎盤特異性蛋白9(PLAC9)多克隆抗體 Polyclonal Antibody to Placenta Specific Protein 9 (PLAC9)
kl079Ov01 白介素6(IL6)多克隆抗體 Polyclonal Antibody to Interleukin 6 (IL6)
kl080Ov01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Rb51 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Si01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl133Ov01 腫瘤壞死因子α(TNFα)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
kl133Rb51 腫瘤壞死因子α(TNFα)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
kl853Hu02 胱天蛋白酶8(CASP8)多克隆抗體 Polyclonal Antibody to Caskle 8 (CASP8)
